NEW YORK, Dec. 21 /PRNewswire-FirstCall/ -- Medicsight PLC, a subsidiary of MGT Capital Investments, Inc. (Amex: MGT), and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software which assists in the early detection of disease, welcomes the initiative by Barbara Cubin, Republican Representative for Wyoming, to introduce legislation to increase patient access to Computed Tomography Colonography (CTC). CTC is the innovative screening test for colorectal cancer that has the potential to save thousands of lives.
Cubin's bill (H.R. 4879, the Virtual Screening for Cancer Act (VSCA) of 2007) includes CTC as a colorectal cancer screening test covered under Medicare. CTC, also known as "virtual colonoscopy" (VC), offers a non-invasive and cost-effective means of detecting early stage cancer of the colon. In addition to expanding Medicare coverage to include virtual colonoscopy, Cubin's bill would also make CTC exams part of the "Welcome to Medicare" program in which Medicare beneficiaries would have their personal co-payments for virtual colonoscopies waived if the exam is conducted within the first six months of enrolment in Medicare, as is currently the case for optical colonoscopy examinations and mammograms. Cubin, who is a Member of the House Energy and Commerce Health Subcommittee, has worked with the medical community to craft this legislation. Democrat Representative Edolphus Towns (New York) joined Cubin as an original co-sponsor of her bill.
In a statement issued yesterday Cubin said: "Colorectal cancer is the
third leading cause of cancer death in the United States today. Early
detection is the most effective method we have to combat this killer.
Unfortunately, too many Americans
|SOURCE MGT Capital Investments, Inc.|
Copyright©2007 PR Newswire.
All rights reserved